Assessing the Real-World, Long-Term Impact of Lemborexant on Sleep Quality in a Home-Based Clinical Study
Open Access
- 1 March 2024
- journal article
- research article
- Published by Taylor & Francis in Nature and Science of Sleep
- Vol. ume 16, 291-303
Abstract
Purpose: Both subjective and objective evaluations are essential for the treatment of insomnia. Lemborexant has been shown to be effective in the long-term based solely on a subjective basis, and no long-term objective measures have been evaluated under natural sleep conditions. Small, lightweight sleep electroencephalogram (EEG) monitor was used, instead of polysomnography, to objectively evaluate sleep at home 4 and 12 weeks after lemborexant treatment. Patients and Methods: Adults and elderly subjects with insomnia disorder, per the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, were enrolled in this open-label, single-arm, single-center trial. Objective and subjective measures of sleep were prospectively assessed. Sleep disturbance, excessive sleepiness, and depressive symptoms were assessed using questionnaires. Results: A total of 45 subjects were screened, of which 33 were enrolled. Paired t-tests were conducted to evaluate changes in sleep variables and compared with the baseline; subjects showed significant improvements in objective sleep efficiency (SE) and subjective sleep parameters at weeks 4 and 12 following treatment with lemborexant. When baseline values were taken into account, a repeated-multivariate analysis of variance (MANOVA) revealed statistically significant changes in the objective measures. Sleep disturbance, excessive sleepiness, and depressive symptoms improved after three months of lemborexant treatment. Conclusion: Furthermore, lemborexant therapy improved nocturnal sleep, when measured objectively using sleep EEG monitoring at home, and improved daytime sleepiness and depressive symptoms in older adults with insomnia disorder.Keywords
This publication has 46 references indexed in Scilit:
- Epidemiology of insomnia disorder in older persons according to the Diagnostic and Statistical Manual of Mental Disorders: a systematic review and meta-analysisEuropean Geriatric Medicine, 2023
- InsomniaClinics in Geriatric Medicine, 2021
- Sleep quality and glycaemic variability in a real-life setting in adults with type 1 diabetesDiabetologia, 2021
- Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia DisorderJAMA Network Open, 2019
- Association of Chronic Insomnia With Mortality and Adverse Renal OutcomesMayo Clinic Proceedings, 2018
- Effects of hypnotics on prefrontal cortex activity during a verbal fluency task in healthy male subjects: A near‐infrared spectroscopy studyHuman Psychopharmacology: Clinical and Experimental, 2018
- Insomnia and risk of dementia in older adults: Systematic review and meta-analysisJournal of Psychiatric Research, 2016
- Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studiesJournal of Affective Disorders, 2011
- Risk Factors Associated With Complaints of Insomnia in a General Adult PopulationArchives of internal medicine (1960), 1992
- The Pittsburgh sleep quality index: A new instrument for psychiatric practice and researchPsychiatry Research, 1989